Probiodrug AG, a German specialist in Alzheimer’s disease, has raised €22.5 million with an initial public offering of its shares on the Amsterdam Euronext exchange. The offering of 1,524,205 shares was priced at €15.25 per share. Kempen & Co acted as the bookrunner.
